title: Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.
authors.affiliation: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA. michael.shetzline@novartis.com
authors.forename: Michael A
authors.initials: MA
authors.lastname: Shetzline
authors.forename: Marielle
authors.initials: M
authors.lastname: Cohard-Radice
authors.forename: Bo
authors.initials: B
authors.lastname: Joelsson
mesh_terms: D017091:Colitis, Ischemic / Q000139:chemically induced*; D003248:Constipation / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*
chemical_list: D007211:Indoles; C105050:tegaserod